Literature DB >> 21321103

Murine Chlamydia trachomatis genital infection is unaltered by depletion of CD4+ T cells and diminished adaptive immunity.

Sandra G Morrison1, Christina M Farris, Gail L Sturdevant, William M Whitmire, Richard P Morrison.   

Abstract

Chlamydia muridarum and Chlamydia trachomatis mouse models of genital infection have been used to study chlamydial immunity and vaccine development. To assess the protective role of CD4(+) T cells in resolving C. trachomatis and C. muridarum genital tract infections, we used the female mouse model and evaluated infection in the presence and absence of CD4(+) T cells. In contrast to C. muridarum infection, C. trachomatis infection was unaltered in the absence of CD4(+) T cells. Mice infected with C. trachomatis developed protective immunity to re-challenge, but unlike C. muridarum infection, optimum resistance required multiple infectious challenges, despite the generation of adaptive serum and local chlamydial specific immune responses. Thus, understanding the chlamydial pathogenic and host immunologic factors that result in a diminished protective role for CD4(+) T cells in C. trachomatis murine infection might lead to new insights important to human immunity and vaccine development.
© The Author 2011. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21321103      PMCID: PMC3068022          DOI: 10.1093/infdis/jiq176

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  37 in total

Review 1.  Immunity to murine chlamydial genital infection.

Authors:  Richard P Morrison; Harlan D Caldwell
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

2.  Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39.

Authors:  T D Read; R C Brunham; C Shen; S R Gill; J F Heidelberg; O White; E K Hickey; J Peterson; T Utterback; K Berry; S Bass; K Linher; J Weidman; H Khouri; B Craven; C Bowman; R Dodson; M Gwinn; W Nelson; R DeBoy; J Kolonay; G McClarty; S L Salzberg; J Eisen; C M Fraser
Journal:  Nucleic Acids Res       Date:  2000-03-15       Impact factor: 16.971

3.  Frameshift mutations in a single novel virulence factor alter the in vivo pathogenicity of Chlamydia trachomatis for the female murine genital tract.

Authors:  Gail L Sturdevant; Laszlo Kari; Donald J Gardner; Norma Olivares-Zavaleta; Linnell B Randall; William M Whitmire; John H Carlson; Morgan M Goheen; Elizabeth M Selleck; Craig Martens; Harlan D Caldwell
Journal:  Infect Immun       Date:  2010-06-14       Impact factor: 3.441

4.  Resolution of secondary Chlamydia trachomatis genital tract infection in immune mice with depletion of both CD4+ and CD8+ T cells.

Authors:  S G Morrison; R P Morrison
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

5.  Quantitative culture of Chlamydia trachomatis: relationship of inclusion-forming units produced in culture to clinical manifestations and acute inflammation in urogenital disease.

Authors:  W M Geisler; R J Suchland; W L Whittington; W E Stamm
Journal:  J Infect Dis       Date:  2001-09-28       Impact factor: 5.226

6.  Immunity to murine Chlamydia trachomatis genital tract reinfection involves B cells and CD4(+) T cells but not CD8(+) T cells.

Authors:  S G Morrison; H Su; H D Caldwell; R P Morrison
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

7.  Disease outcome subsequent to primary and secondary urogenital infection with murine or human biovars of Chlamydia trachomatis.

Authors:  K H Ramsey; J L DeWolfe; R D Salyer
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

8.  Chlamydia trachomatis cytotoxicity associated with complete and partial cytotoxin genes.

Authors:  R J Belland; M A Scidmore; D D Crane; D M Hogan; W Whitmire; G McClarty; H D Caldwell
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-13       Impact factor: 11.205

9.  A unique population of extrathymically derived alpha beta TCR+CD4-CD8- T cells with regulatory functions dominates the mouse female genital tract.

Authors:  Martina Johansson; Nils Lycke
Journal:  J Immunol       Date:  2003-02-15       Impact factor: 5.422

10.  Clostridium difficile toxin B is an inflammatory enterotoxin in human intestine.

Authors:  Tor C Savidge; Wei-Hua Pan; Paul Newman; Michael O'brien; Pauline M Anton; Charalabos Pothoulakis
Journal:  Gastroenterology       Date:  2003-08       Impact factor: 22.682

View more
  23 in total

1.  Parenteral vaccination protects against transcervical infection with Chlamydia trachomatis and generate tissue-resident T cells post-challenge.

Authors:  Nina Dieu Nhien Tran Nguyen; Anja W Olsen; Emma Lorenzen; Peter Andersen; Malene Hvid; Frank Follmann; Jes Dietrich
Journal:  NPJ Vaccines       Date:  2020-01-23       Impact factor: 7.344

2.  Immunization with Chlamydia psittaci plasmid-encoded protein CPSIT_p7 induces partial protective immunity against chlamydia lung infection in mice.

Authors:  Yuan Tan; Yumeng Li; Yang Zhang; Jian Yu; Yating Wen; Chuan Wang; Man Xu; Qian Chen; Chunxue Lu; Yimou Wu
Journal:  Immunol Res       Date:  2018-08       Impact factor: 2.829

Review 3.  Animal models for studying female genital tract infection with Chlamydia trachomatis.

Authors:  Evelien De Clercq; Isabelle Kalmar; Daisy Vanrompay
Journal:  Infect Immun       Date:  2013-07-08       Impact factor: 3.441

4.  Chlamydia-Specific IgA Secretion in the Female Reproductive Tract Induced via Per-Oral Immunization Confers Protection against Primary Chlamydia Challenge.

Authors:  Nita Shillova; Savannah E Howe; Besmir Hyseni; Deahneece Ridgell; Derek J Fisher; Vjollca Konjufca
Journal:  Infect Immun       Date:  2020-12-15       Impact factor: 3.441

Review 5.  Diversity in the T cell response to Chlamydia-sum are better than one.

Authors:  Jasmine C Labuda; Stephen J McSorley
Journal:  Immunol Lett       Date:  2018-09-01       Impact factor: 3.685

6.  A T cell epitope-based vaccine protects against chlamydial infection in HLA-DR4 transgenic mice.

Authors:  Weidang Li; Ashlesh K Murthy; Gopala Krishna Lanka; Senthilnath L Chetty; Jieh-Juen Yu; James P Chambers; Guangming Zhong; Thomas G Forsthuber; M Neal Guentzel; Bernard P Arulanandam
Journal:  Vaccine       Date:  2013-10-01       Impact factor: 3.641

7.  Repeated Chlamydia trachomatis infections are associated with lower bacterial loads.

Authors:  K Gupta; R K Bakshi; B Van Der Pol; G Daniel; L Brown; C G Press; R Gorwitz; J Papp; J Y Lee; W M Geisler
Journal:  Epidemiol Infect       Date:  2018-10-04       Impact factor: 2.451

8.  A vaccine formulated with a combination of TLR-2 and TLR-9 adjuvants and the recombinant major outer membrane protein elicits a robust immune response and significant protection against a Chlamydia muridarum challenge.

Authors:  Chunmei Cheng; Sukumar Pal; Delia Tifrea; Zhenyu Jia; Luis M de la Maza
Journal:  Microbes Infect       Date:  2013-11-27       Impact factor: 2.700

9.  Immunoglobulin-specific responses to Chlamydia elementary bodies in individuals with and at risk for genital chlamydial infection.

Authors:  William M Geisler; Sandra G Morrison; Martha L Doemland; Shehzad M Iqbal; Jin Su; Ausra Mancevski; Edward W Hook; Richard P Morrison
Journal:  J Infect Dis       Date:  2012-10-08       Impact factor: 5.226

10.  CD8+ T cells mediate Chlamydia pneumoniae-induced atherosclerosis in mice.

Authors:  Mark T Zafiratos; Srikanth Manam; Kyle K Henderson; Kyle H Ramsey; Ashlesh K Murthy
Journal:  Pathog Dis       Date:  2015-07-27       Impact factor: 3.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.